On December 17, Infinite Healthcare, a global healthcare IT specialist and subsidiary of KOSDAQ-listed Solborn, announced that it has made a bold decision to enhance governance transparency and maximize shareholder value.
On this day, Infinite Healthcare held a board meeting and decided to mutually terminate the 2025 management consulting service contract it had previously signed with its largest shareholder, Solborn Co., Ltd.
As a result of this decision, Infinite Healthcare will cancel the management consulting service contract with Solborn and receive a full refund of all management consulting fees already paid. A company representative stated, "By carrying out management consulting work based on internal capabilities, this move aims to enhance the speed and accountability of decision-making and to more stably implement future shareholder return policies, reflecting the strong commitment of the management team."
In particular, Infinite Healthcare has no plans to enter into management consulting service contracts with Solborn Co., Ltd. in the future. This is seen as a declaration to fundamentally block any potential internal transaction issues that may be raised in the market and to establish a more independent and transparent management system.
A company representative said, "At today's board meeting, in addition to the contract termination, there were in-depth discussions on enhancing shareholder value," adding, "We will continue to review and implement measures that provide tangible benefits to shareholders, such as expanding profit dividends, as was done with the quarterly dividend executed in September last year."
An Infinite Healthcare representative stated, "The termination of this service contract and the announcement to discontinue future contracts are promises to further strengthen efficiency and transparency in management operations and to utilize profits more for the company and shareholders," adding, "We will continue to build a sound governance structure and responsible management to consistently earn the trust of shareholders and the market."
Meanwhile, the company is currently under trading suspension as it has become subject to a substantive delisting review due to a breach of duty by a former co-CEO.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
